Dantrium and haemoglobin decreased Patient Reports February 09, 2010

Dantrium Side Effects Report #5136871-3
Dantrium side effect was reported by a Physician from JAPAN on Oct 11, 2006. Female patient, 72 years of age, was diagnosed with neuroleptic malignant syndrome, parkinson's disease  and was treated with Dantrium. After drug was administered, patient experienced the following side effects: acarodermatitis, gastric ulcer haemorrhage, haematocrit decreased, haemoglobin decreased, neuroleptic malignant syndrome, red blood cell count decreased, urinary tract infection . Dantrium dosage: 20 MG TWICE DAILY, IV NOS. During the same period patient was treated with MADOPAR, AMAZOLON, DOPS, PERGOLIDE MESYLATE, SOLDEM, DEXTROSE, SOLDOL E. Patient recovered.

Dantrium Side Effects Report #5934365-6
Dantrium side effect was reported by a Pharmacist from FRANCE on Oct 13, 2008. Male patient, 55 years of age, was diagnosed with muscle spasticity, hypercholesterolaemia, hypertension and was treated with Dantrium. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase decreased, eosinophil count increased, gastrointestinal motility disorder, haemoglobin decreased, hypercholesterolaemia, hypertension, lymphocyte count decreased, pancreatic pseudocyst, pancreatitis acute. Dantrium dosage: 100MG AM 25MG NOON 50MG PM, ORAL; 175 MG, DAILY, ORAL. During the same period patient was treated with FENOFIBRATE, PRAVASTATIN, CELECTOL, VISKEN, CREON. Patient was hospitalized. Patient recovered.